Area of research
Pulmonary and Respiratory Medicine · Otorhinolaryngology
Research interest
Research focused on Hazard ratio and Lung cancer, with related work in Cisplatin, Proteome, Hesperidin. Notable publications include 'A proteomic landscape of diffuse-type gastric cancer', 'Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer', and 'Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest'.
Antiviral effects and mechanism of Qi pi pill against influenza viruses
Identification of novel protein biomarkers from the blood and urine for the early diagnosis of bladder cancer via proximity extension analysis
Artificial intelligence-based classification of breast lesion from contrast enhanced mammography: a multicenter study
Radiomics nomogram for predicting axillary lymph node metastasis in breast cancer based on DCE-MRI: A multicenter study
Clinical outcomes of carbon‐ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma
Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
A proteomic landscape of diffuse-type gastric cancer
Dietary Cholesterol Intake and Risk of Lung Cancer: A Meta-Analysis
Let-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk
SNHG and UCA1 as prognostic molecular biomarkers in hepatocellular carcinoma: recent research and meta-analysis
Risk of cerebral palsy in Chinese children: A N:M matched case control study
Epigenetic Upregulation of Metallothionein 2A by Diallyl Trisulfide Enhances Chemosensitivity of Human Gastric Cancer Cells to Docetaxel Through Attenuating NF-κB Activation
EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations
Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest
Prognostic relevance and therapeutic implications of centromere protein F expression in patients with esophageal squamous cell carcinoma